Status:
COMPLETED
Impact of Acetazolamide in Reducing Referred Postoperative Pain
Lead Sponsor:
Medical College of Wisconsin
Conditions:
Prostate Cancer
Men
Eligibility:
MALE
18+ years
Phase:
PHASE1
Brief Summary
Robotic assisted laparoscopic prostatectomy (RALP) is the standard treatment for prostate cancer, due to the benefits of decreased blood loss and length of stay.The procedure involves removing a man's...
Eligibility Criteria
Inclusion
- • Male patients ≥18 years of age undergoing robotic-assisted prostatectomy
Exclusion
- Patients with renal insufficiency with serum creatinine \>2.0 mg/dl
- Patients with renal transplant
- Patients with pre-existing metabolic acidosis
- Patients with chronic obstructive pulmonary disease
- Patients with hepatic disease
- Patients with central nervous system disorders
- Patients with hematological disease history
- Patients with pre-existing electrolyte abnormalities
- Patients with hypovolemia
- Patients with lithium or diuretic usage
- Patients with sulfonamides allergy
- Patients with American Society of Anesthesiologists physical status 4 or 5
Key Trial Info
Start Date :
August 22 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 31 2021
Estimated Enrollment :
33 Patients enrolled
Trial Details
Trial ID
NCT04470843
Start Date
August 22 2018
End Date
March 31 2021
Last Update
September 23 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Froedtert Memorial Lutheran Hospital
Milwaukee, Wisconsin, United States, 53226